Enlight Renewable Energy Ltd.·4

May 14, 7:33 AM ET

Yavetz Gilad 4

Research Summary

AI-generated summary

Updated

Enlight (ENLT) Exec Chairman Gilad Yavetz Exercises Options, Sells Shares

What Happened

  • Gilad Yavetz, Executive Chairman of Enlight Renewable Energy (ENLT), exercised derivative awards to acquire 77,210 ordinary shares on 2026-05-13 (exercise price ~$23.22/share; total exercise cost $1,792,816). Following the exercise, shares were withheld to cover taxes/exercise obligations (20,721 shares, valued at $1,901,773) and 100,000 shares were sold in open-market transactions at $91.78/share for total gross proceeds of $9,178,000. The filing also shows a derivative conversion/disposition entry for 77,210 shares at $0, which is a reporting detail tied to the exercise.

Key Details

  • Transaction date: 2026-05-13; Form 4 filed 2026-05-14.
  • Exercise: 77,210 shares at $23.22/share (converted from NIS 71.89; total $1,792,816) — code M.
  • Withholding/payment: 20,721 shares surrendered to company for exercise price/taxes (value reported $1,901,773) — code F (footnote F3).
  • Open-market sales: 56,489 shares and 43,511 shares sold at $91.78/share (NIS 267.00 converted at rate in footnote F4), total proceeds $9,178,000 — code S.
  • Derivative disposition line: 77,210 shares at $0 appears as a conversion/settlement reporting item.
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Filing timeliness: reported within one day of the transaction (no late-file indicator).

Context

  • This is a common “cashless” style sequence: options/exercisable derivatives were exercised and then shares were either withheld to cover taxes/exercise costs or sold in the open market. Such transactions often reflect routine option exercises and liquidity events rather than a directional statement about company prospects.
  • Relevant footnotes: exercise and sale prices were converted from NIS to USD using Bank of Israel rates (see F1 and F4). Footnote F3 confirms shares were retained by the company to cover the exercise price and were not excess withholdings.
  • No indication in the provided data that this was part of a pre-arranged 10b5-1 plan or that the filing was late.